Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# Ossium Health

## Sitemaps

- [XML Sitemap](https://ossiumhealth.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Newsroom](https://ossiumhealth.com/newsroom/)
- [First Pediatric Transplant with Ossium Bone Marrow](https://ossiumhealth.com/first-pediatric-transplant-with-ossium-bone-marrow/) - Physicians at Riley Children’s Health at Indiana University (IU) Health have performed the first pediatric bone marrow transplant using Ossium's off-the-shelf bone marrow. This milestone extends a treatment approach that has shown encouraging results in adults and is a meaningful step in expanding donor options for children. The 14-year-old patient was diagnosed with acute myeloid
- [Ossium Health Hosts Facility Tour and Reception for Indiana Governor Mike Braun and Healthcare Leaders](https://ossiumhealth.com/ossium-health-hosts-facility-tour-and-reception-for-indiana-governor-mike-braun-and-healthcare-leaders/) - Indianapolis Biotech Marks Growing Milestone in the Fight Against Blood Cancer INDIANAPOLIS--(BUSINESS WIRE)--This week, Ossium Health hosted a facility tour and reception at its Indianapolis production facility, bringing together Indiana state officials and healthcare leaders to celebrate the company's pioneering work in cell therapy and its contribution to Indiana's growing biotech economy. Indiana Governor Mike
- [Forbes Selects Ossium as One of America’s Best Startup Employers](https://ossiumhealth.com/forbes-selects-ossium-as-one-of-americas-best-startup-employers/) - For the second time in three years, Ossium Health has been named to Forbes’ list of America’s Best Startup Employers. This annual list highlights a select group of U.S. startups that demonstrate excellence in employee satisfaction, employer reputation, and organizational growth—criteria that reflect not only business performance, but the strength of a company’s culture and
- [First Round Capital Backs Ossium](https://ossiumhealth.com/first-round-capital-backs-ossium/) - Leading venture capital firm First Round Capital -- early investors in Uber, Square, Flatiron Health and more than 250 other companies -- has backed Ossium Health. The San Francisco, New York, and Philadelphia based VC specializes in early stage companies, pairing its "seed investments" with a suite of company-building services for its portfolio companies.
- [Ossium Awarded Phase I Grant from NIH](https://ossiumhealth.com/ossium-wins-phase-i-grant-from-national-institute-of-health/) - The National Institutes of Health notified Ossium that its proposal to demonstrate that the pool of viable, deceased donors for bone marrow transplants includes tissue donors -- deceased donors who do not satisfy all of the health requirements of organ donors -- is likely to be accepted. The NIH's decision to support Ossium's research could
- [Ossium CEO, Kevin Caldwell, featured on Flux podcast](https://ossiumhealth.com/ossium-ceo-featured-on-flux-podcast/) - Kevin Caldwell, Ossium's Co-Founder & CEO, was featured on the latest podcast from Flux. Kevin chats with Flux's Alice Lloyd George about Ossium's mission, the history of bone marrow transplants, and the future of medicine.
- [Ossium Health and Columbia University Irving Medical Center Initiate Phase 1 Study Using Bone Marrow Stem Cells to Minimize Immunosuppression Requirements in Intestinal Transplantation](https://ossiumhealth.com/ossium-health-and-columbia-university-irving-medical-center-initiate-phase-1-study-using-bone-marrow-stem-cells-to-minimize-immunosuppression-requirements-in-intestinal-transplantation/) - Intestinal transplantation is lifesaving for patients with injury or disease of the intestines, but surgical success is hampered by high rejection rates resulting from an immune attack of the recipient against the donor, termed host-vs-graft reactivity. The high levels of immunosuppression historically required to prevent rejection drive elevated risk of infections and cancer. Ossium and
- [Excellthera and Ossium Health Announce a Collaboration to Advance Their Technologies and Platforms to Improve Human Health](https://ossiumhealth.com/excellthera-and-ossium-health-announce-a-collaboration-to-advance-their-technologies-and-platforms-to-improve-human-health/) - ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, and Ossium Health, a therapeutics company harnessing the power of stem cell science to improve treatment for patients with blood and immune diseases, announced on April 21 a collaboration agreement to evaluate
- [Scaling a World-Class Team in 2021](https://ossiumhealth.com/scaling-a-world-class-team-in-2021/) - Here at Ossium, we know that hiring the right people is the most important part of building a great team, so we are very happy to announce that we have welcomed more than 35 new all-star employees over the past 6 months. We have more than doubled in size and now have almost 70 employees
- [Venture Stories Podcast with Co-Founder, President & CEO, Kevin Caldwell](https://ossiumhealth.com/venture-stories-podcast-with-co-founder-president-ceo-kevin-caldwell/) - Co-Founder, President & CEO, Kevin Caldwell talks about the mission and inspiration of Ossium Health in a recent Venture Stories podcast hosted by Village Global. Listen here!
- [3D Heals Podcast with Co-Founder, President & CEO, Kevin Caldwell](https://ossiumhealth.com/3d-heals-podcast-with-co-founder-president-ceo-kevin-caldwell/) - 3DHEALS invites technological game-changers, entrepreneurs, venture capitalists, world-class clinicians, scientists, and other expert stakeholders to have deep-dive conversations on how to re-invent healthcare using 3D printing, bioprinting, and related emerging technologies. Dr. Jenny Chen speaks with our Co-Founder, President, and CEO, Kevin Caldwell, about Kevin's personal journey as an entrepreneur, how such a bone marrow/stem
- [LifeGift and Ossium Health Offer Hope with Bone Marrow Clinical Application](https://ossiumhealth.com/lifegift-and-ossium-health/) - (Houston – July 26, 2021) – LifeGift, the organ procurement organization (OPO) facilitating organ and tissue donation in Southeast, West, and North Texas, and Ossium Health, a therapeutics company harnessing the power of stem cell science to improve treatment for patients with blood and immune diseases, are proud to announce a collaborative partnership. In 2017, LifeGift
- [The Return to the Office in San Francisco](https://ossiumhealth.com/the-return-to-the-office-in-san-francisco/) - Since the beginning of the pandemic, our facility in Indianapolis has had business-critical employees onsite to keep our production and manufacturing operations running smoothly. As a science-based company, we have followed the latest data-backed policies and advisories of the CDC and local governments. We are proud of our team in Indianapolis for staying safe and
- [Battling Blood Cancer at Ossium](https://ossiumhealth.com/battling-blood-cancer-at-ossium/) - September is Blood Cancer Awareness Month, a time to raise awareness about the many ongoing efforts to fight blood cancer and to remember the hundreds of thousands of patients who have passed away due to these devastating conditions. Blood cancer encompasses disorders that affect the blood, bone marrow, and lymphatic system. Depending on the type
- [A Day in the Lab](https://ossiumhealth.com/a-day-in-the-lab/) - As a biotech company, we are in the business of helping people. We go to work with the mission to improve the health, vitality, and longevity of human beings through bioengineering. The individuals who work in our lab embody these values in their daily work making innovative cell therapy products for patients in need. With
- [A Letter from Our CEO](https://ossiumhealth.com/a-letter-from-our-ceo/) - Here at Ossium, we publish monthly internal newsletters highlighting company updates and accomplishments. Each newsletter also includes a brief note from our CEO, Kevin Caldwell. In February’s edition, Kevin reflected on all of the progress we made in 2021, despite facing a host of challenges as a company and society. Check out Kevin’s letter below.
- [Ossium Health Announces FDA Clearance of its Investigational New Drug Application for Treatment of Perianal Fistulizing Crohn’s Disease](https://ossiumhealth.com/ossium-health-announces-fda-clearance-of-its-investigational-new-drug-application-for-treatment-of-perianal-fistulizing-crohns-disease/) - SAN FRANCISCO (March 16, 2022) - Ossium Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for OSSM-001, a mesenchymal stem cell (MSC) product, for the treatment of refractory perianal fistulas in patients with Crohn’s disease. Ossium plans to initiate patient screening and enrollment
- [Ossium Celebrates National Donate Life Month](https://ossiumhealth.com/ossium-health-celebrates-national-donate-life-month/) - The San Francisco (top) and Indianapolis (bottom) Ossium teams wearing their Blue and Green for Donate Life Month This April, Ossium Health continues to be a proud supporter of National Donate Life Month. Founded in 2003 by Donate Life America and its partnering organizations, National Donate Life Month is an opportunity to celebrate those who
- [Ossium Health's First Meeting on the Mesa](https://ossiumhealth.com/meeting_on_the_mesa/) - Kevin Caldwell, Ossium's Co-Founder & CEO, gave a presentation about Ossium and the Promise of Bone Marrow Banking at Meeting on the Mesa, one of the year's biggest biotech conferences that brings together senior executives and top decision-makers in the Cell & Gene therapy industry to share their companies' clinical and commercial progress in the
- [Ossium's CEO, Kevin Caldwell, featured on BioAge Podcast](https://ossiumhealth.com/ossiums-ceo-kevin-caldwell-featured-on-bioage-podcast/) - Kevin Caldwell, Ossium's CEO & Co-Founder, was featured on the latest episode of Translating Aging, a podcast produced by BioAge Labs featuring entrepreneurs and scientists who are advancing the science of human longevity and developing therapeutics to extend the human healthspan. In this episode, Kevin speaks with host Chris Patil, PhD, about Ossium’s groundbreaking
- [Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine (CIRM) to Advance GVHD Program](https://ossiumhealth.com/ossium-health-cirm-grant/) - Ossium Health, Inc. announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the company a $3.46M Clinical Stage Research Program (CLIN1) grant to support the continued clinical development of OSSM-007, Ossium’s interferon-gamma primed mesenchymal stem cell product, for the treatment of steroid-refractory acute graft versus host disease (GVHD). This funding will support
- [Ossium Health Secures $52M Series C to Expand Bone Marrow Bank, Advance Clinical Trials](https://ossiumhealth.com/series-c/) - Ossium Health, Inc. a bioengineering company developing the world's first bank of on-demand bone marrow, today announced a $52 million Series C funding round. The round was led by CPMG, with participation from Vivo Capital, First Round Capital, Manta Ray Ventures, Alumni Ventures, and Asahi Kasei. The company is improving the health, vitality, and longevity
- [Ossium Health® and Be The Match® Unveil Partnership to Increase Bone Marrow Transplant Accessibility and Treatment Efficiency](https://ossiumhealth.com/ossium-health-and-be-the-match-unveil-partnership-to-increase-bone-marrow-transplant-accessibility-and-treatment-efficiency/) - Ossium Health, an innovative bioengineering company, is accelerating its mission to revolutionize the field of bone marrow transplantation through a new partnership with the National Marrow Donor Program (NMDP)/Be The Match, which manages the most diverse registry of blood stem cell donors and cord blood units in the world. This collaboration will enable blood cancer patients to
- [Ossium Health Featured in Nasdaq Live from MarketSite](https://ossiumhealth.com/ossium-health-featured-in-nasdaq-live-from-marketsite/) - Kevin Caldwell, CEO, Co-Founder & President of Ossium Health, recently sat down for an interview with Nasdaq's Kristina Ayanian at their New York headquarters. In the interview, Kevin explained how Ossium is leveraging its organ donor-derived bone marrow platform to improve the accessibility and quality of leukemia treatments today and develop innovative therapies for organ
- [Healio Article Highlights PRESERVE I Study](https://ossiumhealth.com/healio-article-highlights-preserve-i-study/) - The first-in-human study of Ossium’s bone marrow (PRESERVE I) was recently featured in an article published by Healio, a major medical news source for healthcare professionals. The article includes an interview with Kevin Caldwell, CEO, Co-Founder & President of Ossium Health, and Erin Leckrone, Vice President of Clinical Trials at the National Marrow Donor Program
- [First Patient Treated with OssiGraft](https://ossiumhealth.com/first-patient-treated-with-ossigraft/) - Ossium Health announced today that the first patient has been treated with its newly released OssiGraft™ viable bone matrix (VBM) allograft in an ankle surgery. OssiGraft is Ossium’s viable bone matrix allograft, which is intended for use in orthopedic surgery to repair, replace, or reconstruct bone defects. This surgery represents Ossium’s transition from a clinical-stage
- [Ossium Presents at Organ Donation Congress](https://ossiumhealth.com/ossium-presents-at-organ-donation-congress/) - Kevin Caldwell recently presented an update on our bone marrow transplant study at the 2023 Congress of the International Society for Organ Donation and Procurement.
- [Ossium Presents at Meeting on the Mesa](https://ossiumhealth.com/ossium-presents-at-meeting-on-the-mesa/) - At our second appearance at the Cell & Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine, Ossium CEO Kevin Caldwell presented an update on our work over the past year and outlined our vision for the future of bone marrow transplantation. In the presentation, Kevin explained how we’re transforming the bone
- [Lauren Barnes Joins Ossium Health’s Board of Directors](https://ossiumhealth.com/lauren-barnes-joins-ossium-healths-board-of-directors/) - We’re thrilled to announce that we’ve elected Lauren Barnes to our Board of Directors. Barnes is a leading expert in healthcare product commercialization, pricing, reimbursement, market access, and managed markets for products spanning various market segments. This addition significantly bolsters our capacity to drive growth and deliver life-changing solutions for patients suffering from hematologic diseases,
- [Ossium Health Named to Forbes’ List of America's Best Startup Employers](https://ossiumhealth.com/ossium-health-named-to-forbes-list-of-americas-best-startup-employers/) - We’re proud to announce that we’ve been named to Forbes' prestigious list of America's Best Startup Employers! This recognition places us among the top 500 U.S. startups based on employee satisfaction, reputation, and company growth. This award reflects our dedication to fostering a work environment that attracts and retains exceptional talent. Ossium employees are driven
- [Ossium Launches HOPE Program](https://ossiumhealth.com/ossium-launches-hope-program/) - Ossium recently introduced a new program that further expands access to Ossium’s bone marrow to patients around the globe. Through the HOPE (HPC Offered for PRESERVE Expansion) Program, patients that need an allogeneic bone marrow transplant but cannot participate in Ossium’s active clinical study (PRESERVE I) have a new opportunity to receive bone marrow from
- [Ossium featured in NYSE Floor Talk](https://ossiumhealth.com/ossium-featured-in-nyse-floor-talk/) - Ossium CEO Kevin Caldwell recently visited the NYSE and was interviewed on the trading floor. In Kevin’s conversation with the NYSE’s Judy Shaw, they discussed unmet needs and inequities in the current system for finding bone marrow donors and how Ossium is solving those problems by transforming the process for bone marrow donor acquisition. As
- [First Surgery with OssiGraft Prime Highlights its Exceptional Utility](https://ossiumhealth.com/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility/) - Our next-generation viable bone matrix, OssiGraft Prime™, has been released and used in surgery for the first time. OssiGraft Prime builds upon the success of Ossium’s established OssiGraft™ and incorporates innovative processing advancements. The result is a more cohesive product with a gum-like consistency precisely engineered to meet the demands of orthopedic and spine surgeons.
- [Ossium Ranks No. 56 on Fast Company’s 100 Best Workplaces for Innovators](https://ossiumhealth.com/ossium-ranks-no-56-on-fast-companys-100-best-workplaces-for-innovators/) - Fast Company announced its sixth annual Best Workplaces for Innovators list, honoring organizations and businesses that demonstrate an inspiring commitment to encourage and develop innovation at all levels. Ossium came in at No. 56 for its company culture that encourages innovation from every corner of the organization. In addition, Ossium is a finalist on the
- [Ossium Health Reports Positive Initial Outcomes for First Ever Leukemia Patient Treated with Organ Donor Derived Bone Marrow](https://ossiumhealth.com/ossium-health-reports-positive-initial-outcomes-for-first-ever-leukemia-patient-treated-with-organ-donor-derived-bone-marrow/) - Ossium Health, a clinical-stage bioengineering company that built a first-of-its-kind organ donor-derived bone marrow bank to deploy hematopoietic stem cells for blood cancer treatment, announced positive preliminary outcomes for its first leukemia patient. In Detroit, a 68-year-old female diagnosed with acute myeloid leukemia required an urgent bone marrow transplant following an unsuccessful four-month search for
- [Ossium Health Secures BARDA Contract to Advance Bone Marrow Bank for Radiological and Nuclear Emergencies](https://ossiumhealth.com/ossium-health-secures-barda-contract-to-advance-bone-marrow-bank-for-radiological-and-nuclear-emergencies/) - Ossium Health, a commercial-stage bioengineering company with the first-of-its-kind bone marrow bank for processing and deploying stem cell-based therapies, today announced the signing of a contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to advance
- [Ossium in the News](https://ossiumhealth.com/ossium-in-the-news/) - After we reported the first transplant with Ossium’s organ donor bone marrow, several news outlets published stories on this milestone and what it means for the future of stem cell accessibility. Across an array of national, local, and medical news sources, medical experts and journalists chimed in about the significance of this development, calling it
- [Ossium to Exhibit at Tandem in Honolulu](https://ossiumhealth.com/ossium-to-exhibit-at-tandem-in-honolulu/) - We’re excited to announce that Ossium will be exhibiting at the 2025 Transplantation & Cellular Therapy (Tandem) Meetings of ASTCT and CIBMTR, taking place from February 12-15 in Honolulu, Hawaii. This premier event brings together experts and professionals in the field of transplantation and cellular therapy to discuss the latest advancements, research, and innovations shaping
- [Susannah Cantrell Joins Ossium Health as Chief Commercial Officer](https://ossiumhealth.com/susannah-cantrell-joins-ossium-health-as-chief-commercial-officer/) - Susannah Cantrell, PhD, has joined Ossium Health's leadership team as Chief Commercial Officer (CCO).
- [Ossium Health to Present New Clinical Data on Its Organ Donor Bone Marrow at ASH 2025](https://ossiumhealth.com/ossium-health-to-present-new-clinical-data-on-its-organ-donor-bone-marrow-at-ash-2025/) - SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a bioengineering company that developed a first-of-its-kind bank of bone marrow available on-demand, will present new clinical data at the at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition held December 6-9, 2025 in Orlando, Florida. Ossium’s key abstract includes clinical data from four patients with hematologic malignancies
- [Peer-Reviewed Study Establishes Consistent Quality and Early Clinical Success of Ossium’s Proprietary Off-the-Shelf Bone Marrow](https://ossiumhealth.com/peer-reviewed-study-establishes-consistent-quality-and-early-clinical-success-of-ossiums-proprietary-off-the-shelf-bone-marrow/) - SAN FRANCISCO--(BUSINESS WIRE)--A new peer-reviewed study published in Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), reports early clinical experience using Ossium Health’s organ donor-derived, cryopreserved bone marrow as an off-the-shelf graft source for allogeneic hematopoietic cell transplantation (alloHCT). The study provides the most comprehensive description to date of a fully centralized,
- [Ossium Health to Present New Clinical Data from PRESERVE I Study at the 2026 Tandem Meetings](https://ossiumhealth.com/ossium-health-to-present-new-clinical-data-from-preserve-i-study-at-the-2026-tandem-meetings/) - SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a clinical-stage biotechnology company pioneering off-the-shelf bone marrow therapies derived from deceased organ donors, today announced it will present new clinical data from its ongoing PRESERVE I study at the 2026 Tandem Meetings taking place on February 4-7, 2026 in Salt Lake City, UT. Ossium will deliver one oral presentation and

## Pages

- [Homepage](https://ossiumhealth.com/)
- [Platform](https://ossiumhealth.com/platform/)
- [Company About](https://ossiumhealth.com/company/)
- [Publications](https://ossiumhealth.com/publications/) - Hematopoietic stem cells from organ donors lead to long-term multi-lineage engraftment in NSG mice L.M. Breyer, H. Wang, H. Ma, D. Gu, B.H. Johnstone, S. Pan, E.J. Woods, M.Y. MaparaBone Marrow Transplantation, (April 2026) DOI: 10.1038/s41409-026-02864-7 Summary: This study demonstrates that CD34⁺ hematopoietic stem and progenitor cells from deceased organ donors can successfully engraft and
- [Ossium Health's Certificates and Licenses](https://ossiumhealth.com/certificates-and-licenses/) - Certificates and Licenses FDA Tissue Establishment Registration AATB certificate CLIA certificate CAP participation certificate State tissue bank registrations and permits: Delaware Tissue Bank Letter Illinois Tissue Bank Registration Maryland Tissue Permit California Tissue Bank License Oregon Registration Letter
- [Ossium's HOPE Program](https://ossiumhealth.com/hope/) - Expanded access to our bone marrow product for transplant outside of the clinical study.
- [Recovery Partner Onboarding](https://ossiumhealth.com/rp-onboarding/) - Ossium Health's new partner onboarding process and Donor Operations overview.
- [Partners](https://ossiumhealth.com/partners/)
- [Careers](https://ossiumhealth.com/careers/)
- [OssiGraft](https://ossiumhealth.com/ossigraft/)
- [OPO Video](https://ossiumhealth.com/opo-video/)
- [Products](https://ossiumhealth.com/products/)
- [Legal Policies](https://ossiumhealth.com/legal-policies/)
- [Consumer Health Data Policy](https://ossiumhealth.com/consumer-health-data-policy/)
- [Visit us at AAOS Booth #4238](https://ossiumhealth.com/ossigraft-aaos2024/)
- [Human Selected CD34+ Stem Cells (GMP)](https://ossiumhealth.com/human-selected-cd34-stem-cells-gmp/) - Product Description Ossium’s CD34+ cells are aseptically selected from the bone marrow of vertebral bodies by density gradient and positive immunomagnetic separation. The standard GMP vial contains 25M CD34+ cells, though other volumes may be available upon request. Product Name SKU Quantity GMP Selected CD34+ Cells from HPC, Marrow INVC-005-25 25 million cell / vial
- [Sebastian Giwa](https://ossiumhealth.com/sebastian-giwa/) - On February 8, 2016, Ossium Health was incorporated in Delaware. From 2016 to 2018, Sebastian Giwa held different roles at Ossium until he submitted a signed letter of resignation to the company’s Board of Directors on October 19, 2018. Since his resignation, Sebastian Giwa has not had any role with Ossium Health in any capacity,
- [RUO Mesenchymal Stem Cells](https://ossiumhealth.com/ruo-human-mesenchymal-stem-cells/) - Product Description Ossium’s RUO MSCs are derived from the vertebral bodies of organ donors and are phenotypically and functionally equivalent to MSCs obtained from aspirated BM. Product Name SKU Quantity RUO Cryopreserved MSCs, Passage 2 INVR-001-1 1 million cell / vial RUO Cryopreserved MSCs, Passage 4 INVR-002-1 1 million cell / vial Characterization The cells
- [RUO Human Selected CD34+ Stem Cells](https://ossiumhealth.com/human-selected-cd34-stem-cells-ruo/) - Product Description Ossium's RUO CD34+ cells are aseptically selected from the bone marrow of vertebral bodies by density gradient and positive immunomagnetic separation. Product Name SKU Quantity RUO Selected CD34+ Cells from HPC, Marrow INVR-003-0.5 500,000 cell / vial RUO Selected CD34+ Cells from HPC, Marrow INVR-003-1 1 million cell / vial RUO Selected CD34+
- [GMP Human Mesenchymal Stem Cells](https://ossiumhealth.com/msc-cgmp/) - Product Description Ossium's GMP MSCs are derived from the vertebral bodies of organ donors and are phenotypically and functionally equivalent to MSCs obtained from aspirated BM. Product Name SKU Quantity GMP Cryopreserved vBM MSCs, Passage 4 INVC-006-100 100 million cell / vial Characterization The cells express typical MSC surface markers (CD73, CD90, and CD105), lack
- [Terms & Conditions](https://ossiumhealth.com/ruo-terms-and-conditions/)
- [Ossium Health Jobs](https://ossiumhealth.com/jd/)
- [Our Team](https://ossiumhealth.com/our-team-2/)
- [Thanks for subscribing](https://ossiumhealth.com/thanks-for-subscribing/) - Thank you for subscribing to our newsletter. Back to Homepage
- [Thank You](https://ossiumhealth.com/thank-you/) - Thank you for contacting Ossium. We will review your message shortly. Back to Homepage
- [Contact Us](https://ossiumhealth.com/contact-us/) - Headquarters 80 Tehama St,San Francisco, CA 94105(415) 513-5535 Facility 5742 W 74th St,Indianapolis, IN 46278
- [Our Team](https://ossiumhealth.com/our-team/)
- [Job Details](https://ossiumhealth.com/old-careers/job/)
- [Attribution](https://ossiumhealth.com/attribution/) - Coming soon.

## People

- [Cody Martinez](https://ossiumhealth.com/people/cody-martinez/)
- [Shea Kreinbrink](https://ossiumhealth.com/people/shea-kreinbrink/)
- [Joan McNicholl](https://ossiumhealth.com/people/joan-mcnicholl/)
- [Logan Ayres](https://ossiumhealth.com/people/logan-ayres/)
- [Holden Martin](https://ossiumhealth.com/people/holden-martin/)
- [Brennan Bochenek](https://ossiumhealth.com/people/brennan-bochenek/)
- [Kevin Campbell](https://ossiumhealth.com/people/kevin-campbell/)
- [Kofi Quist](https://ossiumhealth.com/people/kofi-quist/)
- [Sam Scott](https://ossiumhealth.com/people/sam-scott/)
- [Hillary Harris](https://ossiumhealth.com/people/hillary-harris/)
- [Aryan Khadiri](https://ossiumhealth.com/people/aryan-khadiri/)
- [Meghann Pierce](https://ossiumhealth.com/people/meghann-pierce/)
- [Davis Belt](https://ossiumhealth.com/people/davis-belt/)
- [Samantha Dusthimer](https://ossiumhealth.com/people/samantha-dusthimer/)
- [Allie Perez](https://ossiumhealth.com/people/allie-perez/)
- [Jen Win](https://ossiumhealth.com/people/jenny-win/)
- [Kelsey Musall](https://ossiumhealth.com/people/kelsey-musall/)
- [Firmo Sanchez](https://ossiumhealth.com/people/firmo-sanchez/)
- [Alexa Burke](https://ossiumhealth.com/people/alexa-burke/)
- [Kourtney Woods](https://ossiumhealth.com/people/kourtney-woods/)
- [Hannah Miller](https://ossiumhealth.com/people/hannah-miller/)
- [Collin Malone](https://ossiumhealth.com/people/collin-malone/)
- [Nikisha Hatcher](https://ossiumhealth.com/people/nikisha-hatcher/)
- [Jessica Bridgham](https://ossiumhealth.com/people/jessica-bridgham/)
- [Brianna Sedam](https://ossiumhealth.com/people/brianna-sedam/)
- [Liz Turoldo](https://ossiumhealth.com/people/liz-turoldo/)
- [Kevin Blankenberger](https://ossiumhealth.com/people/kevin-blankenberger/)
- [Alyssa Ochoa-Mena](https://ossiumhealth.com/people/alyssa-ochoa-mena/)
- [Termeh Shamloo](https://ossiumhealth.com/people/termeh-shamloo/)
- [Matt Gregory](https://ossiumhealth.com/people/matt-gregory/)
- [Chelsea Wheeler](https://ossiumhealth.com/people/chelsea-wheeler/)
- [Scott Needham](https://ossiumhealth.com/people/scott-needham/)
- [Kerry Gray](https://ossiumhealth.com/people/kerry-gray/)
- [Andrew Bruhn](https://ossiumhealth.com/people/andrew-bruhn/)
- [Jessica Merchant](https://ossiumhealth.com/people/jessica-merchant/)
- [Lisa Quiroga](https://ossiumhealth.com/people/lisa-quiroga/)
- [Sarah Bryan](https://ossiumhealth.com/people/sarah-bryan/)
- [Zak Piekarski](https://ossiumhealth.com/people/zak-piekarski/)
- [Carla Cochran](https://ossiumhealth.com/people/carla-cochran/)
- [Elisa Hartman](https://ossiumhealth.com/people/elisa-weber/)
- [Vicki Graves](https://ossiumhealth.com/people/vicki-graves/)
- [Leo Page](https://ossiumhealth.com/people/leo-page/)
- [Lakin Schoen](https://ossiumhealth.com/people/lakin-schoen/)
- [Brett Bowersock](https://ossiumhealth.com/people/brett-bowersock/)
- [Alicia Nenedjian](https://ossiumhealth.com/people/alicia-nenedjian/)
- [Logan Jilek](https://ossiumhealth.com/people/logan-jilek/)
- [Abbi Newkirk](https://ossiumhealth.com/people/abbi-newkirk/)
- [Erika Jackson](https://ossiumhealth.com/people/erika-jackson/)
- [Brianna Lowery](https://ossiumhealth.com/people/brianna-lowery/)
- [Jonathan Smith](https://ossiumhealth.com/people/jonathan-smith/)
- [Zach Neighbors](https://ossiumhealth.com/people/zach-neighbors/)
- [Cody Shoopman](https://ossiumhealth.com/people/cody-shoopman/)
- [Tarun Krishnan](https://ossiumhealth.com/people/tarun-krishnan/)
- [Erina Suganuma](https://ossiumhealth.com/people/erina-suganuma/)
- [Susannah Cantrell](https://ossiumhealth.com/people/susannah-cantrell/)
- [Curtis Yaggi](https://ossiumhealth.com/people/curtis-yaggi/)
- [Valeria Guzman](https://ossiumhealth.com/people/valeria-guzman/)
- [Kayla Jackson](https://ossiumhealth.com/people/kayla-jackson/)
- [Kimberly Buchanan](https://ossiumhealth.com/people/kimberly-buchanan/)
- [Max Jacobs](https://ossiumhealth.com/people/max-jacobs/)
- [Winston Woodfork](https://ossiumhealth.com/people/winston-woodfork/)
- [Caroline McPhail](https://ossiumhealth.com/people/caroline-mcphail/)
- [Tyler Hoodlebrink](https://ossiumhealth.com/people/tyler-hoodlebrink/)
- [Hans Nowak](https://ossiumhealth.com/people/hans-nowak/)
- [Justin Souder](https://ossiumhealth.com/people/justin-souder/)
- [Fred Sides](https://ossiumhealth.com/people/fred-sides/)
- [Dawson Ray](https://ossiumhealth.com/people/dawson-ray/)
- [Laurenlee Tritle](https://ossiumhealth.com/people/laurenlee-tritle/)
- [Sarah Roberts](https://ossiumhealth.com/people/sarah-roberts/)
- [Matt Shadday](https://ossiumhealth.com/people/matt-shadday/)
- [Ashley Collins](https://ossiumhealth.com/people/ashley-collins/)
- [Melany Magrone](https://ossiumhealth.com/people/melany-magrone/)
- [Jie Jiang](https://ossiumhealth.com/people/jie-jiang/)
- [Joyce Abad](https://ossiumhealth.com/people/joyce-abad/)
- [Roger Chen](https://ossiumhealth.com/people/roger-chen/)
- [Sagar Munjal](https://ossiumhealth.com/people/sagar-munjal/)
- [Dongsheng Gu](https://ossiumhealth.com/people/dongsheng-gu/)
- [Kim Okoro](https://ossiumhealth.com/people/kim-lusk/)
- [Ryan Dobias](https://ossiumhealth.com/people/ryan-dobias/)
- [Abby Brar](https://ossiumhealth.com/people/abby-brar/)
- [Behdad Pournader](https://ossiumhealth.com/people/behdad-pournader/)
- [Nathan Chinni](https://ossiumhealth.com/people/nathan-chinni/)
- [Courtney Harker-Lane](https://ossiumhealth.com/people/courtney-harker-lane/)
- [Roxana Hunt](https://ossiumhealth.com/people/roxana-hunt/)
- [Preethi Prasad](https://ossiumhealth.com/people/preethi-prasad/)
- [Aubrey Sherry](https://ossiumhealth.com/people/aubrey-sherry/)
- [Omar Herrera](https://ossiumhealth.com/people/omar-herrera/)
- [Nick Weinstein](https://ossiumhealth.com/people/nick-weinstein/)
- [Nick Niehaus](https://ossiumhealth.com/people/nick-niehaus/)
- [Neal Hoffman](https://ossiumhealth.com/people/neal-hoffman/)
- [Jane Griffin](https://ossiumhealth.com/people/jane-griffin/)
- [Kathleen Vasilopulos](https://ossiumhealth.com/people/kathleen-vasilopulos/)
- [Kelly Dawson](https://ossiumhealth.com/people/kelly-dawson/)
- [Kaylee Smith](https://ossiumhealth.com/people/kaylee-smith/)
- [Jason Eder](https://ossiumhealth.com/people/jason-eder/)
- [Kevin Caldwell](https://ossiumhealth.com/people/kevins-bio-2/)
- [Ed Jun](https://ossiumhealth.com/people/ed-jun/)
- [Brian Johnstone](https://ossiumhealth.com/people/brian-johnstone/)
- [Jay Gardner](https://ossiumhealth.com/people/jay-gardner/)
- [Chip Walker-Wilson](https://ossiumhealth.com/people/chip-walker-wilson/)
- [Erik Woods](https://ossiumhealth.com/people/kevins-bio/)
- [Jason Mattiello](https://ossiumhealth.com/people/jason-mattiello/)
- [Emma Arndt](https://ossiumhealth.com/people/emma-arndt/)
- [Kileen Moore](https://ossiumhealth.com/people/kileen-moore/)
- [Ethan Seiders](https://ossiumhealth.com/people/ethan-seiders/)
- [Shannon Knapp](https://ossiumhealth.com/people/shannon-knapp/)
- [Lucas Tabor](https://ossiumhealth.com/people/lucas-tabor/)
- [Kevin Cox](https://ossiumhealth.com/people/kevin-cox/)
- [Christopher Carpenter](https://ossiumhealth.com/people/christopher-carpenter/)
- [Brian Legg](https://ossiumhealth.com/people/brian-legg/)
- [W. Scott Goebel](https://ossiumhealth.com/people/w-scott-goebel/)

## FAQs

- [Can I be tested to see if I’m a match for my friend/family/etc. through this program?](https://ossiumhealth.com/ufaq/can-i-be-tested-to-see-if-im-a-match-for-my-friend-family-etc-through-this-program/) - No. Ossium exclusively processes bone marrow from deceased organ donors and does not process bone marrow from living donors.
- [Can I donate bone marrow through this program?](https://ossiumhealth.com/ufaq/can-i-donate-bone-marrow-through-this-program/) - No. Ossium’s bone marrow bank is sourced from deceased organ donors and we do not bank bone marrow from living donors.
- [Who will perform the bone marrow transplant?](https://ossiumhealth.com/ufaq/who-will-perform-the-bone-marrow-transplant/) - The doctor you’re already seeing will perform the transplant. Any qualified bone marrow transplant physician can perform a transplant with bone marrow from our bank.
- [How can patients benefit from participating in this program?](https://ossiumhealth.com/ufaq/how-can-blood-cancer-patients-benefit-from-participating-in-this-program/) - This program provides patients with a unique mechanism to access bone marrow from our bank even if they cannot participate in the PRESERVE I clinical study. Bone marrow from our bank could provide benefits to the patient, including increased donor choice, decreased time to transplant, and optimal cell dose.
- [Who can participate in this program?](https://ossiumhealth.com/ufaq/second-question/) - Adults with blood disorders that are unable to participate in the PRESERVE I clinical study may be eligible to participate in the HOPE Program. The patient’s doctor must determine that they are eligible for an allogeneic bone marrow transplant and that the potential benefits outweigh the potential risks. The determination on program eligibility is made
- [What is the HOPE Program?](https://ossiumhealth.com/ufaq/first-question/) - The HOPE Program provides an opportunity for patients with blood disorders to receive bone marrow from our bank when they can’t participate in the PRESERVE I clinical study.
- [Who can I (or my doctor) contact with questions?](https://ossiumhealth.com/ufaq/who-can-i-or-my-doctor-contact-with-questions/) - You can reach Ossium’s patient support team at hope@ossiumhealth.com or (628) 677-4863.
- [What does it cost to participate?](https://ossiumhealth.com/ufaq/what-does-it-cost-to-participate/) - We will provide bone marrow to HOPE Program patients at no cost. The bone marrow transplant procedure itself is not covered by Ossium. This is considered a medical procedure that is treated the same as a transplant from a living donor. We encourage participants to seek information from the transplant center and their health insurance
- [What precautions are taken to ensure Ossium’s bone marrow is safe for use?](https://ossiumhealth.com/ufaq/what-precautions-are-taken-to-ensure-ossiums-bone-marrow-is-safe-for-use-in-humans/) - Bone marrow donors in Ossium’s bank undergo rigorous screening and testing for relevant communicable disease agents by both the Organ Procurement Organizations and a dedicated donor management team at Ossium Health. Ossium donors have been confirmed by our Medical Director to be free from risk factors for, and clinical evidence of, infection due to relevant
- [How can I find out if there’s a bone marrow match in the Ossium bank?](https://ossiumhealth.com/ufaq/how-can-i-find-out-if-theres-a-bone-marrow-match-in-the-ossium-bank/) - After you express interest in participating in this program by completing the form above, we’ll request additional information from you and your doctor to determine whether there’s a matching donor in our bank. Once your doctor provides your HLA type, we can search for a matching donor. We will keep you informed on every step
- [Where does Ossium’s bone marrow come from?](https://ossiumhealth.com/ufaq/where-does-ossiums-bone-marrow-come-from/) - Bone marrow in our bank is derived from the vertebrae of consented and rigorously screened organ donors. We obtain vertebral bodies from organ donors through partnerships with the organizations responsible for solid organ procurement and distribution in the US. The vertebral bodies are processed in our production facility under a highly controlled process and stored

## Categories

- [Uncategorized](https://ossiumhealth.com/category/uncategorized/)
- [Press Release](https://ossiumhealth.com/category/press-release/)
- [Career](https://ossiumhealth.com/category/career/)
- [News](https://ossiumhealth.com/category/news/)
- [General](https://ossiumhealth.com/category/general/)
- [Clinical Trials](https://ossiumhealth.com/category/clinical-trials/)

## Roles

- [Leadership](https://ossiumhealth.com/role/leadership/)
- [Testimonial](https://ossiumhealth.com/role/testimonial/)